Seongnam-si, South Korea

Eun Kyung Kim

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Hwaseong-si, KR (2021 - 2022)
  • Seongnam-si, KR (2016 - 2023)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Eun Kyung Kim: Innovator in Pharmaceutical Compositions

Introduction

Eun Kyung Kim is a prominent inventor based in Seongnam-si, South Korea. She has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. Her work primarily focuses on innovative compounds that exhibit therapeutic potential.

Latest Patents

Among her latest patents are formulations involving triazolones, tetrazolones, and imidazolones, or their salts, along with pharmaceutical compositions that include these compounds. The technology she developed provides preparation processes and applications for these compounds, which demonstrate inhibitory activity on VAP-1. This makes them useful for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH). Additionally, she has patented triazolopyridin-3-ones or their salts, which also show similar inhibitory activity and therapeutic applications.

Career Highlights

Eun Kyung Kim has worked with notable companies such as Yuhan Corporation and Nhn Entertainment Corporation. Her experience in these organizations has allowed her to advance her research and development in pharmaceutical innovations.

Collaborations

She has collaborated with colleagues including Hee Jae Tak and Tae Dong Han, contributing to her success in the field.

Conclusion

Eun Kyung Kim's innovative work in pharmaceutical compositions and her extensive patent portfolio highlight her significant impact on the industry. Her contributions continue to pave the way for advancements in the treatment of various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…